{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T14:56:46Z","timestamp":1758121006140},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,12]],"date-time":"2013-08-12T00:00:00Z","timestamp":1376265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30901268"],"award-info":[{"award-number":["30901268"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Health Research Foundation of Shaanxi Province","award":["2010H31"],"award-info":[{"award-number":["2010H31"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.bjid.2013.02.004","type":"journal-article","created":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T13:45:52Z","timestamp":1372772752000},"page":"601-605","source":"Crossref","is-referenced-by-count":13,"title":["Splenectomy prior to antiviral therapy in patients with hepatitis C virus related decompensated cirrhosis"],"prefix":"10.1016","volume":"17","author":[{"given":"Fanpu","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2013.02.004_bib0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjid.2013.02.004_bib0010","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1413-8670(10)70070-2","article-title":"Long-term follow-up of patients with chronic hepatitis C with sustained virologic response to interferon","volume":"14","author":"Ferreira Sda","year":"2010","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.bjid.2013.02.004_bib0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1413-8670(10)70093-3","article-title":"Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis","volume":"14","author":"Cheinquer","year":"2010","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.bjid.2013.02.004_bib0020","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jhep.2006.08.020","article-title":"Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: a controlled study","volume":"46","author":"Iacobellis","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.bjid.2013.02.004_bib0025","first-page":"946","article-title":"Short-term efficacy and safety of standard interferon with a low accelerating dosage regimen in HCV-related decompensated cirrhosis","volume":"18","author":"Ji","year":"2010","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.bjid.2013.02.004_bib0030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/jlts.2003.50073","article-title":"Projecting future complications of Chronic hepatitis C in the United States","volume":"9","author":"Davis","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.bjid.2013.02.004_bib0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cgh.2010.10.036","article-title":"Long-term. outcome after antiviral therapy of patients with hepatitis C virus infection and decompensated cirrhosis","volume":"9","author":"Iacobellis","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bjid.2013.02.004_bib0040","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJMoa1104430","article-title":"Preliminary study of two antiviral agents for hepatitis C genotype 1","volume":"366","author":"Lok","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjid.2013.02.004_bib0045","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s00464-009-0653-6","article-title":"Laparoscopic splenectomy with peginterferon and ribavirin therapy for patients with hepatitis C virus cirrhosis and hypersplenism","volume":"24","author":"Akahoshi","year":"2010","journal-title":"Surg Endosc"},{"key":"10.1016\/j.bjid.2013.02.004_bib0050","first-page":"488","article-title":"Splenectomy and antiviral treatment for thrombocytopenic patients with chronic hepatitis C virus infection","volume":"17","author":"Ikezawa","year":"2010","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.bjid.2013.02.004_bib0055","first-page":"18","article-title":"Therapeutic effects of linear stapler pericardial devascularization on portal hypertension: analysis of 52 cases","volume":"14","author":"Li","year":"2009","journal-title":"J Surg Concepts Pract"},{"key":"10.1016\/j.bjid.2013.02.004_bib0060","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bjid.2013.02.004_bib0065","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1413-8670(12)70316-1","article-title":"Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3","volume":"16","author":"Vigani","year":"2012","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.bjid.2013.02.004_bib0070","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bjid.2013.02.004_bib0075","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.3748\/wjg.v12.i13.2089","article-title":"Reduction of virus burden-induced splenectomy in patients with liver cirrhosis related to hepatitis C virus infection","volume":"12","author":"Sekiguchi","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bjid.2013.02.004_bib0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2249.2011.04393.x","article-title":"Modulation of CD4+ T cell responses following splenectomy in hepatitis C virus-related liver cirrhosis","volume":"165","author":"Hashimoto","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.bjid.2013.02.004_bib0085","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2893.2010.01402.x","article-title":"Hepatitis C treatment among racial and ethnic groups in the IDEAL trial","volume":"18","author":"Muir","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.bjid.2013.02.004_bib0090","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bjid.2013.02.004_bib0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep.23976","article-title":"Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients","volume":"53","author":"Yu","year":"2011","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"10.1016\/j.bjid.2013.02.004_bib0100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1478-3231.2011.02702.x","article-title":"Future treatment of patients with HCV cirrhosis","volume":"32","author":"Bourli\u00e8re","year":"2012","journal-title":"Liver Int"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867013001463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867013001463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T21:57:41Z","timestamp":1539554261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867013001463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1413867013001463"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2013.02.004","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}